Last reviewed · How we verify

NCT05210400

Prospectively Assessing Pain After Breast Surgery

Status unknown Last updated 27 January 2022
What this trial tests

trial in Pain, Postoperative in 40 participants. Status unknown.

Timeline
1 March 2022
Primary endpoint
28 February 2024
28 February 2025

Quick facts

Lead sponsorCedars-Sinai Medical Center
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment40
Start date1 March 2022
Primary completion28 February 2024
Estimated completion28 February 2025

Conditions studied

Sponsor

Cedars-Sinai Medical Center

Who can join

18 and older, female only, with Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Reducing post-operative pain and reducing the use of opioid narcotics are independently valuable goals. Before studying newer techniques that may help us achieve these goals, we need objective data on how much pain normally occurs after breast surgery done with standard-of-care techniques. This study was designed to obtain baseline data.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pain, Postoperative

Currently open trials in the same condition.

Other Cedars-Sinai Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05210400.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing